Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!
understanding and management of this disease. George Van Hook. Rail Yard. Oil on linen, 12˝ × 16˝. Primary Cutaneous B-Cell Lymphomas : Recent Advances in Diagnosis and Management Lubomir Sokol, MD, PhD, Mojdeh ...
There have been unprecedented advances in the management of B-cell lymphoma in the last decade. These include staging, treatment, and bench observations. There have been unprecedented advances ...
in Japan. In 2020, we revised the Japanese guidelines for the management of cutaneous lymphomas with consideration of the recent advances in the understanding of the pathophysiology and classification ...
Mycosis fungoides (MF) is a low-grade cutaneous lymphoma accounting for more than half of primary cutaneous T-cell lymphomas (CTCLs). Due to the rarity of CTCL, randomized studies are lacking ...
will focus on recent advances in the development of therapeutic agents, including bortezomib, the histone deacetylase inhibitors (vorinostat and romidepsin), and pralatrexate in CTCL. Cancer Management ...
‐cell lymphoma has led to the emergence of new drugs. Unfortunately, this has not been met with similar advances in outcome improvement. Anthracycline‐containing regimens, mostly cyclophosphamide ...
therapeutic advances in nodal B-cell lymphomas , we focus on the development of novel treatment options applicable to primary cutaneous B-cell lymphomas , including targeted therapies, combination treatments ...
T‐cell lymphomas (TCLs) constitute a rare subset of non‐Hodgkin lymphomas , with mycosis fungoides/Sézary syndrome (MF/SS) being the most common subtype of cutaneous TCLs (CTCLs). Considered ...
meetings. Mycosis fungoides (MF) is the most common type of cutaneous lymphoma . In this review, we will highlight some of the recent advances in our understanding of the clinicopathogenetic features ...
Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!